Which symptom should the nurse closely monitor for in patients with Paget's disease?

Joint stiffness is a common symptom in patients with Paget's disease, especially when bone deformities are present. The nurse should closely monitor for any changes in joint mobility and range of motion, as joint stiffness can impact the patient's ability to perform daily activities.

a. Weight gain: Weight gain is not a specific symptom of Paget's disease. It is not directly related to the condition.

c. Hyperactivity: Hyperactivity is not a characteristic symptom of Paget's disease. The condition primarily affects bone structures.

d. Blurred vision: Blurred vision is not associated with Paget's disease. It is not a symptom commonly observed in individuals with the condition.

Bisphosphonates are commonly used as the first-line treatment for Paget's disease. They work by slowing down bone resorption and promoting more balanced bone remodeling, helping to control the excessive bone turnover characteristic of the condition.

a. Calcium supplements: While calcium supplements are essential for overall bone health, they are not the first-line treatment for Paget's disease. Bisphosphonates specifically target the abnormal bone remodeling associated with the condition.

b. Nonsteroidal anti-inflammatory drugs (NSAIDs): NSAIDs may help manage pain and inflammation associated with Paget's disease, but they do not directly address the underlying bone remodeling abnormalities. Bisphosphonates are more effective in treating the condition.

d. Vitamin D supplements: Vitamin D is necessary for calcium absorption and bone health, but it is not the primary treatment for Paget's disease. Bisphosphonates are the mainstay of therapy.